Treatment of Cooley's anemia [see comments]
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 • 6,910 citations
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 • 3,401 citations
Iron metabolism in man
1979 • 726 citations
Bone Marrow Transplantation in Patients with Thalassemia
1990 • 632 citations
The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism
1964 • 620 citations
Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
1986 • 430 citations
Magnetic-Susceptibility Measurement of Human Iron Stores
1982 • 374 citations
Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia Major
1985 • 272 citations
OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE
1983 • 269 citations
1 Iron toxicity and oxygen radicals
1989 • 252 citations
Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative
1989 • 244 citations
The Clinical Approach to Thalassaemia
1984 • 228 citations
Deferoxamine-induced growth retardation in patients with thalassemia major
1988 • 207 citations
IRON METABOLISM. IRON STORES IN MAN AS MEASURED BY PHLEBOTOMY 1
1952 • 178 citations
Growth and sexual maturation in thalassemia major
1985 • 162 citations
11 The toxic effects of desferrioxamine
1989 • 138 citations
Transfusion Therapy in Cooley's Anemia: Growth and Health as Related to Long‐Range Hemoglobin Levels. A Progress Report
1964 • 132 citations
2 The development of iron chelating drugs
1989 • 129 citations
Marrow Transplantation in Patients with Advanced Thalassemia
1987 • 126 citations
Compliance with oral drug therapy in patients with hematologic malignancy.
1987 • 116 citations
PREVENTION OF BONE MALFORMATIONS AND CARDIOMEGALY IN COOLEY'S ANEMIA BY EARLY HYPERTRANSFUSION REGIMEN*
1969 • 86 citations
Marrow transplantation for thalassemia.
1986 • 84 citations
Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy
1989 • 72 citations
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?
1989 • 61 citations
Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy.
1985 • 55 citations
Iron overload and desferrioxamine chelation therapy in β-thalassemia intermedia
1981 • 54 citations
Advances in the prenatal diagnosis of hematologic diseases
1984 • 53 citations
Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects.
1985 • 51 citations
Control of homozygous β‐thalassemia by carrier screening and antenatal diagnosis in Sardinians
1984 • 42 citations
Current Therapy in Hematology-Oncology
1992 • 40 citations
CLINICAL EXPERIENCE WITH INTENSIVE TRANSFUSION THERAPY IN COOLEY'S ANEMIA*
1969 • 38 citations
Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients
1989 • 27 citations
6 Diagnosis and clinical evaluation of iron overload
1989 • 27 citations
Posttransfusion hepatitis: clinical features, risk and donor testing.
1985 • 22 citations
Nuclear resonance scattering measurement of human iron stores
1985 • 18 citations
Cardiac Disease–free Survival in Patients with Thalassemia Major Treated with Subcutaneous Deferoxamine
1990 • 17 citations
Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia major
1989 • 12 citations
Oral iron chelators.
1990 • 12 citations
[Treatment of post-transfusion iron overload by deferoxamine].
1989 • 9 citations
Bone Mrrow Transplantation in β-Twiassemia Major the Israeli Experience
1988 • 8 citations
Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
1969 • 5 citations